Standorte

Company

Locations

Edelstahlbau Tannroda GmbH

Edelstahlbau Tannroda GmbH
Bad Berkaer Straße 10
99438 Bad Berka

Tel: +49 (0)3 64 50 | 3 86-0
Fax: +49 (0)3 64 50 | 3 86-50
E-Mail: info@edelstahlbau.de

You are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information
Unblock content Accept required service and unblock content

Edelstahlbau Tannroda GmbH

Edelstahlbau Tannroda GmbH
Betriebsstätte Ilmenau
Auf dem Steine 3
98693 Ilmenau
Tel: +49 36450 386-20 
Fax: +49 36450 386-50 
E-Mail: info@edelstahlbau.de 

You are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information
Unblock content Accept required service and unblock content

EST Andrä Grafittechnik GmbH

Auf dem Steine 3
98693 Ilmenau
Tel: +49(0) 3677 202431
Fax: +49(0) 3677 62723
info@est-grafittechnik.de
http://www.est-andrae-grafit.de

You are currently viewing a placeholder content from Google Maps. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information
Unblock content Accept required service and unblock content

Dear Sir or Madam,
Dear Mr Weinert,
27.04.2021


On April 30, 2021, we will open another site at Allergopharma GmbH & Co. KG in Reinbek to support COVID 19 vaccine production in the presence of Federal Minister Spahn and Minister President Günther. We would have been pleased to invite you to this opening.

Unfortunately, this was not possible due to the pandemic.
We would therefore like to take this opportunity to thank you for your extraordinary commitment to supplying equipment at short notice to support vaccine production. Allergopharma, as part of Dermapharm Holding SE, is now a further partner in the Europe-wide production network for the vaccine of BioNTech and Pfizer. This network now comprises more than a dozen important pharmaceutical manufacturers and suppliers. From now on, one of four production steps will take place in Reinbek: the vaccine formulation. This is where our mRNA active ingredient is combined with the lipids. A protective shell is created around the mRNA and the vaccine can reach its target in the body to induce the necessary immune response.


Your company has made a very important contribution to the global pandemic response with great know-how and under incredible time pressure. We would like to express our sincere thanks to you and your team! Without their commitment, the successful completion of the project would not have been possible.
We look forward to working with you in partnership in the future!

Dr. Hans-Georg Feldmeier – CEO Dermapharm SE
Dr. Sierk Poetting – CFO and COO BioNTech SE